Ignite Creation Date:
2025-12-24 @ 12:37 PM
Ignite Modification Date:
2025-12-27 @ 10:44 PM
Study NCT ID:
NCT00354861
Status:
COMPLETED
Last Update Posted:
2008-04-25
First Post:
2006-07-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized Phase I Study of a Hepatitis B Antigen Combined With IMP321
Sponsor:
Immutep S.A.S.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
P002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
F. Triebel, Chief Medical Officer
Old Organization:
Immutep S.A.
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |